Fingerprint
Dive into the research topics of 'Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
Howard A. Fine, William D. Figg, Kurt Jaeckle, Patrick Y. Wen, Athanassios P. Kyritsis, Jay S. Loeffler, Victor A. Levin, Peter M. Black, Richard Kaplan, James M. Pluda, W. K.Alfred Yung
Research output: Contribution to journal › Article › peer-review
393
Scopus
citations